SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " run " 9,420 found 🔀 AI-powered Shuffle
Michigan’s Democratic Senate primary carries 2020 echoes: From the Politics Desk
Plus, Trump’s voting plans run into resistance.
Netflix and Superheroes Are Having a Rough Stretch on Streaming....
(Welcome to my weekly streaming ratings report, the single best guide to what’s popular in streaming TV and what isn’t. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. If you were forwarded this email, please subscribe to get these insights each week.) I have a quick prediction before we start today’s article: You might see this data in future news articles. Not my specific charts or analysis, but the core trend I’ve been monitoring—Netflix is having a lackluster Q2—will become inescapable. Often, folks want to know “What does the data say?” Well, that’s what it says. I haven’t seen this analysis hit the trades really yet, but I have a feeling some other outlets are going to start making this case soon. Remember, you read it here first. You probably have read about the problems facing superhero films at the box office this weekend. Well, this week, I explore whether superheroes are dying on TV as well! And the data says: definitely maybe! We have a lot to cover in today’s Streaming Ratings Report, which covers the two weeks of 18-May and 25-May. Today, I’m just looking at TV, like Netflix’s disappointing Q2, superhero shows underwhelming, a few TV shows dropping off the charts, The Pitt finally ending its epic run on the viewership charts (and whether “view counts” change its status as one of the biggest shows of all time), all the flops, bombs and misses, and a whole lot more. Tomorrow, I’ve got a great rundown of the film side of things. Let’s dive right in! (Reminder: The streaming ratings report focuses on the U.S. market and compiles data from Nielsen’s weekly top ten viewership ranks, Luminate’s Top Ten Data, Showlabs, TV Time trend data, Samba TV household viewership, company datecdotes, Netflix hours viewed data, Google Trends, and IMDb to determine the most popular content. While most data points are current, Nielsen’s data covers the weeks of May 18th to May 31st, 2026. You can find a link to my terminology here.) Subscribe Television - Netflix’s Q2 Slump Continues Having analyzed streaming ratings for going on half a decade, I have learned to trust my gut, but I’m always relieved when I can find actual data to back it up. For example, after a string of very popular shows like Stranger Things, Bridgerton, The Lincoln Lawyer and The Night Agent came out, week after week, in January and February, my gut wondered if Netflix had enough new and returning TV shows to sustain them throughout the year. Since then, Netflix’s post-March slate of shows has not impressed me. This week seemed to feature a potential new hit, but then, like a classic Duffer Bros. TV show, there was a twist. I speak of The Boroughs, Netflix’s latest (and last) Duffer Bros. produced show. The pitch is “Stranger Things with older actors”. And it topped the Nielsen charts: With just two weeks of viewership, The Boroughs would have been a top 25 debut show last year: But here’s the twist: Netflix has already cancelled The Boroughs! What happened? Likely a few things. First, the show didn’t do as well globally as it did in the US. As What’s on Netflix showed, it lagged behind several other shows that got cancelled. Second, its completion rate was likely low; after an initial burst of interest, it quickly dropped off on the Samba TV and Luminate charts. Third, the Duffer Bros. left Netflix for Paramount, and that may have factored into Netflix’s decision here. (Though I tend to believe that if a show is doing well, Netflix would have kept greenlighting seasons.) Still, just because I can explain why Netflix may have cancelled this show doesn’t mean I’m justifying it. In particular, as I’ve noted before, Netflix is losing a lot of their bigger shows as they reach their natural ends, and they need to replace those shows. This show had the hallmarks of a big new genre show, and it’s their biggest hit of the last few months (in the US at least), but now it’s done. Netflix’s other show this week—The Four Seasons, the second season of the “hit” show from last year—definitely disappointed. Its sophomore season had about half the viewership of the first, only 12.7 million hours. It also only had a two week run on Samba TV, and its numbers were all down on Luminate too. In other words, even with two successes, the Q2 slump for Netflix looks real: I could add to the list of disappointments: Both Lord of the Files and Man on Fire had short runs on the Nielsen charts. Running Point’s sophomore season also opened to about half its viewership, similar to The Four Seasons. A Good Girl’s Guide to Murder’s second season—see below—didn’t even make any of the three viewership charts I track, unlike the first season. Netflix is absolutely having a dismal second three months of 2026. If this Nielsen data is any indication, and I think it is, I think this will show up in Netflix’s engagement report, and maybe even their financial outcomes. And the rest of June doesn’t look much better. We have two hit shows coming back—Sweet Magnolias, one of their quietest big shows, and Avatar: The Last Airbender, a big hit for them in 2024—but the other big swings are limited series crime thrillers i.e. no future season potential. Like I said above, sometimes when I uncover a juicy nugget like this, other outlets end up writing very similar articles mimicking the data without credit. We’ll see if that happens this time! Share Television - The State of Superhero Shows on Streaming When I first heard the pitch for Spider-Noir—a Sony TV show on Prime Video that binge-released eight episodes first on MGM+ then on Prime Video two days later—I had my doubts. It’s a live-action Spider-Man show set in the 1930s, starring Nicholas Cage, based on a cameo of a character in Spider-Man: Into the Spider-Verse. No, seriously, that’s the pitch. That could either go terrifically well or horribly wrong. Great because, Spider-Man. He’s the biggest superhero we have. I’ve seen tracking numbers that put the new _Spider-Man: Brand New Da_y as the blockbuster of the year and initial pre-sales back that up. And yet this Spider-Noir pitch feels very esoteric. (Also, the eight-episode binge release feels very “Amazon copying Netflix” again.) So what’s the data say? And what does this say about the future of superhero shows?
Chiefs Honor Former Running Back Joe Delaney on Death Anniversary
Kansas City missed the playoffs for the first time in the Patrick Mahomes era last season, finishing 6-11. Before last season, Mahomes had led the Chiefs to at least the AFC championship game every year prior.
Gemini's personalized AI image generation is now free for U.S. users
Google is expanding Gemini’s personalized AI image generation to eligible free users in the U.S., allowing the chatbot to create images based on your interests and data from connected Google apps.
2026 Best of 225 Awards: People & Entertainment
From best chef and best photographer to best live music venue and best performing arts group, here are the 2026 Best of 225 Award winners and runners-up in the people and entertainment category.
Pierce Johnson's NSFW Reds-Pirates HR reaction gets Jomboy treatment
Reds relief pitcher Pierce Johnson had an animated, NSFW reaction to allowing an eighth-inning home run in Pittsburgh.
Watch out, Amazon: the Kobo eReader now has a Goodreads rival
Kobo users can now automatically sync their reading progress to StoryGraph, making it easier to track books, reading stats, and challenges without relying on Amazon’s Goodreads.
Gene Off Script: Are politicians embracing socialism?
Are politicians embracing socialism? Many candidates running for elected positions are being asked if they renounce socialism.
3 teams in running for Darnell Nurse trade with Oilers
Edmonton continues to look for ways to trade the veteran defenseman.
Arena, the AI leaderboard everyone uses, is now a $100M business
The startup, which runs a popular free AI leaderboard, launched its commercial service just last September.
Arkansas basketball coach John Calipari to be inducted into Memphis Sports Hall of Fame
Calipari reached the NCAA Tournament six times with Memphis, including a national runner-up finish in 2008, and won the 2002 NIT title.
Cursor now has a mobile app for guiding your coding agent on the go
Cursor has launched a new mobile app for remote oversight over coding agents.
Former Tennessee Titans running back Chris Johnson reveals a devastating health diagnosis
Two-time All-Pro Chris Johnson reveals diagnosis at age 40.
TIDAL cracks down on AI music by cutting off monetization
TIDAL's new policy will prevent AI-generated music from making money on its service.
New York Stock Exchange opening bell to be rung from Oval Office for Trump Accounts launch
The New York Stock Exchange will be opened from the Oval Office next week to mark the opening of Trump Accounts, White House economic adviser Kevin Hassett said Monday.
Dem running for Pelosi’s seat mocked after anti-Israel hecklers chase him from SF Trans March
Videos show state Sen. Scott Wiener being shouted down by anti-Israel activists in San Francisco, sparking widespread mockery from conservatives.
BYU-Idaho Launches BYUI Live! as New Name for Campus Entertainment
From chart-topping bands and Broadway stars to comedians and inspirational performers, live entertainment has become a valued part of the BYU-Idaho experience. Brigham Young University-Idaho is pleased to announce the rebranding of its long-running Center Stage series as BYUI Live!—a new name that reflects the university's vision to create memorable live entertainment experiences that bring BYU-Idaho students and the surrounding community together.
Booming Business: Texas Secures Top Spot for Climate Fourth Year Running
Texas was recognized as the Best Business Climate in the nation for the fourth year in a row by Business Facilities magazine in their 2026 Annual Rankings Report.
Former NFL star Chris Johnson makes heartbreaking health announcement
The NFL is filled with gridiron legends who sacrifice their bodies every Sunday in pursuit of a Super Bowl championship. But even the game’s greatest stars aren’t invincible. On Monday, former Tennessee Titans running back Chris Johnson revealed that he…
This Compact, Emission-Free Gas Turbine Is Rocket Science
This week’s Current Climate newsletter also looks at America lagging in EVs and charging infrastructure, and Sunrun’s transformation into a company
Former Titans running back Chris Johnson announces ALS diagnosis
Former Tennessee Titans running back Chris Johnson announced he has been diagnosed with amyotrophic lateral sclerosis, or ALS.
Flipper Device's new Busy Bar is a customizable display for productivity
Flipper Device's new Busy Bar will retail for $249.
Remembering Joe Delaney, 43 years after he died
24-year-old running back gave his life to try to save three children.
Kakao Entertainment Announces Genre-Spanning Lineup
Kakao Entertainment enjoyed a highly successful first half of the year, with its Netflix series “The WONDERfools” and “Boyfriend on Demand” hitting global home runs with their distinctive narratives. Also building on the recently released suspense drama “Notes from the Last Row,” Kakao Entertainment’s genre-spanning 2026 slate features the upcoming action-comedy “A Bona Fide Killer” and the thriller “Mousetrap,” cementing - Read our full Pop Culture on The Outerhaven .
New look, same sole: Charm City Run founder keeps Baltimore moving
In Good Company: Josh Levinson made Charm City Run specifically for Baltimore. For nearly 25 years, the region has loved the business back.
The science of a splashdown: Why only 7 home runs have reached the Allegheny River on the fly
They gathered in their brightly colored kayaks and rubber rafts, several dozen of them at least. There along the north shore of the Allegheny River they...
Central Florida Congressional races attract out-of-district candidates
After long-time U.S. Representative Daniel Webster announced his retirement in April, potential successors quickly filed to run for the open Central Florida seat. But of the eight major-party candidates who
Tilak Varma enters unwanted record books after slowest-ever...
Tilak Varma's resilient half-century was a lone bright spot for India in their narrow one-run loss to Ireland, despite becoming one of the slowest Indian fifties in T20Is. Walking in during a top-order collapse, Varma battled tough conditions to reach his milestone. Ultimately, Ireland secured a historic series win, ending India's impressive streak.
Is this World Cup now Europe v South America? Which giants fall today? Day 18 recap
Sunday was the strangest day of this World Cup, in that there was only one match, sandwiched between days with six and three respectively. This was for scheduling reasons: no third-placed sides could have played on Sunday, given that the identity of the eight sides and their precise fixtures had only been decided on Saturday night. It would also have been impossible to organise fixtures between any other winners and runners-up while also giving them a reasonable — and relatively similar — number of days since their final group stage fixture. In the game that did happen, co-hosts Canada...
Nintendo Switch eShop latest sales: lowest prices ever for TMNT: Shredder's Revenge, Tomb Raider 4-6, Witcher 3, more
A bunch of new sales are up and running on the North American Nintendo Switch eShop. These include the lowest prices ever for Teenage Mutant Ninja Turtles: Shredder’s Revenge, Tomb Raider 4-6 Remastered, The Witcher 3: Wild Hunt, and more. Here’s the full roundup: – .hack//G.U. Last Recode – $9.99 (was $49.99) – A Boy and His Blob – $6.74...
Running through challenges: Elite runner returns to Missoula Half Marathon after health complications
Abby Rodseth finished as the 11th woman in the Missoula Half Marathon, completing an emotional return to competitive running.
Trump calls likely DC mayor Janeese Lewis George a 'communist' and vows to block her agenda
D.C. mayoral frontrunner Janeese Lewis George faces clash with President Trump over ICE enforcement, policing, cashless bail and sanctuary city policies.
Mets drop tough one in series finale
A.J. Ewing nearly had his Mets moment, but a Kyle Schwarber home run ruined the fun on Sunday afternoon.
Stephen Eustáquio's late goal sends Canada to the World Cup Round of 16 in a 1-0 win over South Africa
Canada's World Cup run is still alive.
I Put Apple CarPlay In My Wife's 2006 Toyota 4Runner And I'm Never Looking Back
Despite its 300,000 miles we're not getting rid of the 4Runner anytime soon, so it was worth making a small investment to bring its infotainment into the 2020s.
Kelsey Grammer says he’s considering a run for political office
Grammer, who met with Trump on Thursday, has hinted that his political aspirations may manifest “in some way” in the coming years.
Miles Bridges trade grades: Suns burn another potential rebuild year, Hornets add to draft pick pile
The asset-rich Charlotte front office got a home run return with the 2033 first-round pick
Cowboys 2026 roster rundown: TE Brevyn Spann-Ford
Cowboys tight end will make his push for more playing time
U.S. Rep. Julia Letlow, endorsed by Trump, wins the GOP primary for Senate in Louisiana
Letlow, who was endorsed by Trump, defeated state Treasurer John Fleming in the two-candidate runoff after they finished ahead of Cassidy in the GOP primary May 16.
American Airlines flight aborts takeoff at MIA after business jet enters runway
An American Airlines flight to Bermuda aborted its takeoff after a business jet entered the same runway at Miami International Airport on Saturday evening.
Reproduction affects health—and so does biological sex
Starting one's sex life and having children at a young age can run in the family. But can pregnancy have beneficial health effects, and do the partner's genes contribute to them? "We are just beginning ...
Govee's smart nugget ice maker makes every iced drink feel like a luxury
For some people, the ice in a beverage is almost as important as the drink itself. That's the audience Govee had in mind when designing its latest ice
Grease is the word at Sutter Street
FOLSOM — Sutter Street Theatre will transport audiences back to the halls of Rydell High this summer with its production of “Grease: School Version,” running through July 26.
Chicago Cubs news
Seiya Suzuki was the lone bright spot in the Cubs 6-2 loss Friday, hitting his 11th home run of the season
The AI Politics of 2028 Are Starting Now
Gina Raimondo and Eric Holcomb are not running for president. They might drive the 2028 agenda on artificial intelligence anyway.
With time running out, Trump digs in on changing midterm election rules
Fearing a Democratic takeover of Congress, the president has spent months trying to alter how the midterms will be conducted, but obstacles keep cropping up.
'High-strung' camels race in Australian outback
Camels with "a bit of fire in them" raced in a remote Australian outback town this weekend at an annual event celebrating the desert beasts first imported in the mid-19th century."You would want a little bit of temper, a little bit of fire in them -- a sort of splashy look in the eye," Woodhouse told AFP. "They want to be wary of you a little bit but not, like, aggressive," he added.
2026 World Cup Betting Report: 'USA Is By Far Our Worst Result In The Book'
There's no way around it: The USA making a deep run at the World Cup would be a horrendous result for sportsbooks. Patrick Everson reports.
Trump gets the complete domination he wanted in Louisiana
Rep. Julia Letlow, his preferred candidate, won the GOP runoff for his longtime rival Bill Cassidy’s Senate seat.
Padres outmatched by Dodgers with nine run inning
SAN DIEGO - Just when things started to look like the San Diego Padres found a resurgence after winning four in-a-row against two of the best teams in league, they run into a mack truck-like force called the Los Angeles Dodgers.
Hunter Goodman smashes three home runs vs. Twins
Colorado Rockies designated hitter Hunter Goodman hit three long home runs against the Minnesota Twins on Saturday. Goodman crushed two no-doubters — solo shots in the first and third innings — in his first two at-bats against Twins starter Mike Paredes. Then, after grounding out in the fifth, Goodman came up with two runners on base and the Rockies leading 3-2 in the seventh.
Julia Letlow defeats John Fleming in GOP Senate runoff. Jamie Davis wins Democratic nod.
Letlow staved off a tough challenge from Treasurer John Fleming, while Davis overwhelmingly one his party’s nomination.
Trump-backed Rep. Julia Letlow wins Louisiana Senate primary runoff
Letlow defeated state Treasurer John Fleming in the GOP runoff, NBC News projects. Incumbent Sen. Bill Cassidy did not make the runoff.
American Airlines flight aborts takeoff in Miami after business jet enters the same runway
An American Airlines flight headed to Bermuda aborted its takeoff in Miami Saturday evening after a business jet entered the same runway, getting as close as a third of a mile apart at one point.
American Airlines flight aborts takeoff in Miami after business jet enters the same runway
An American Airlines flight headed to Bermuda aborted its takeoff in Miami Saturday evening after a business jet entered the same runway, getting as close as a third of a mile apart at one point.
Trump-backed Julia Letlow faces John Fleming in Louisiana GOP Senate runoff
U.S. Rep. Julia Letlow, who was endorsed by Trump, and state Treasurer John Fleming are competing in the runoff. The two finished ahead of Sen. Bill Cassidy in the May 16 primary after Trump denounced the two-term senator, who voted to convict him following his 2021 impeachment.
GOP candidate with same name as senator can stay on Alaska ballot, judge rules
Supporters of incumbent Republican Sen. Dan Sullivan say a challenger with the same name is not running in “good faith,” but a judge says that is not an issue.
Jalen Brunson gets a standing ovation at Mariska Hargitay's play after announcing his 'SVU' dream
Jalen Brunson received a standing ovation at Mariska Hargitay's Broadway play 'Every Brilliant Thing.' The New York Knicks star previously stated his desire to guest star on 'Law & Order: SVU.'
Buffalo Bills Make Decision On Honoring O.J. Simpson
As the franchise transitions to a new stadium, officials confirm the legendary running back’s name will be scrubbed from the Wall of Fame, ending a controversial decades-long tribute.
An au pair made my family obsessed with Argentina's World Cup run
What started as childcare turned into a friendship, a World Cup obsession, and a connection that spans two continents.
How Domo went from a $2.8 billion darling to fighting for its survival
Domo has been rocked by executive departures, new competition from AI agents, and the drunken-driving arrest of its founder and CEO, Josh James.
The AI bubble has further to run despite the looming crash
As tech firms make huge profits and investors fear losing out, both are doing their best to hold off the day of reckoning
The fittest founder in the room got cancer. Here's how he used AI to fight back.
When confronted with cancer, Connor Christou fed everything tied tied to his regime — blood results, scan data, wearable output, journal entries — into Claude.
Disgraced Actor's MAGA-Coded Movie Trailer Just Dropped — And The Plot Is WILD
"Run Hide Fight: Infidels" comes almost three years after Majors’ conviction for assaulting his then-girlfriend.
After ousting Bill Cassidy, Donald Trump faces fresh test of his sway with GOP voters in Louisiana’s Senate runoff
Louisiana Republican voters already rejected an incumbent senator who was crossways with President Donald Trump. In a primary runoff on Saturday, they’ll decide whether to follow Trump’s lead in choosing a new nominee.
Country music icons play final show after 6 decades together: ‘What a run we’ve had’
The popular group thanked fans as it took its final bow.
Letlow, Fleming face off for Cassidy's seat in Louisiana GOP Senate runoff
Riding Into 2028: On the Midterms Trail, Andy Beshear Eyes a Bigger Prize
The two-term Democratic governor of deep-red Kentucky, in demand as a surrogate in key 2026 races, talks horses, faith and family politics as he considers a run for the White House.
Meet Troy Rohrbaugh and Doug Petno, who are vying for Jamie Dimon's job
Doug Petno and Troy Rohrbaugh are the frontrunners to succeed Jamie Dimon. Here's a guide to the men in line for one of Wall Street's top jobs.
No debut, but loud cheers: Belfast crowd shows love for Vaibhav Sooryavanshi
Teenage sensation Vaibhav Sooryavanshi's India debut is still pending, but the focus shifted to Ireland's historic 34-run victory in the first T20I. Despite the loss, Shreyas Iyer vowed a strong comeback. Ireland's debutants impressed, with Jai Moondra and Matt Hollard making immediate impacts, while Abhishek Sharma's quickfire fifty wasn't enough for India.
Trump-backed Letlow faces Fleming in Louisiana GOP Senate runoff
President Donald Trump’s choice for U.S. Senate in Louisiana is seeking to secure the GOP nomination and deliver another win for the president in his effort to replace Republicans who crossed him
Presidential ambitions? Moore speech to contrast Trump rally
Wes Moore has repeatedly said he's focused on his role as governor, but political analysts say his actions point to a run for higher office.
The 5-Question Org Chart Audit I Run Before Scaling AI Across a Business
AI success depends less on the technology and more on the organization behind it. These five questions help leaders identify the structural barriers that prevent AI from delivering real business impact.
Live Results: Louisiana midterm primary runoffs
Louisiana Republicans will nominate a candidate for U.S. Senate in a primary runoff Saturday, six weeks after denying Republican U.S. Sen. Bill Cassidy a shot at a third term.
Lloyd Kaufman on How Iconic Troma Entertainment 'Birthed' the MCU
Lloyd Kaufman on running the world's longest-running indie studio, MCU influence, 'Crime and Punishment' adaptation 'The Power of Positive Murder'
‘If you’re running in a Democratic primary, you ought to be a Democrat’: Sen. Coons reacts to NYC primary results
The Venezuela Earthquakes Hit a Health System Already in Crisis
Firefighters are using cellphone lights because of a flashlight shortage, and an overwhelmed hospital in the disaster zone is operating without running water, one doctor said.
Why the Amex Business Gold is my go-to card for business expenses
The Amex Business Gold makes earning rewards simple with automatic bonus categories, flexible Membership Rewards points and statement credits that help offset its annual fee.
Why JD Vance is downplaying Richard Nixon’s corruption
It’s not every day that you see the would-be frontrunner for a major party’s presidential nomination extolling the virtues of Richard Nixon and downplaying his corruption.
We cut MBA prices because America needs more professionals, not fewer
America is running short on educated workers at the exact moment when they matter the most.
Moncks Corner woman, 35, charged after running business without retail license
A Berkely County woman was charged after South Carolina Department of Revenue officals found that she was with operating a business without a Retail LicenseFrid
Kelsey Grammer says he’s considering a run for political office
Grammer, who met with Trump on Thursday, has hinted that his political aspirations may manifest “in some way” in the coming years.
Xprize founder says 'humans behave better when they’re being watched'
Peter Diamandis is the latest tech executive to argue that global surveillance will make the world a better place, following Larry Ellison's comments in 2024.
CBS Sports speculates that Colts’ star could be ‘one of five players to force trade’
Could Colts running back Jonathan Taylor eventually request a trade from Indianapolis?
Last Chance To Fix Destiny 2 Delayed After Bungie Lays Off Devs
Bungie is running out of chances to set things right in its sci-fi MMO before it's left behind for good
Who plays in the World Cup today, June 26?
Here's your daily rundown on Philadelphia's Fan Festival hours and entertainment.
CT Summer Fair brings live entertainment, carnival rides, and more. ‘30,000 expected to celebrate
Suffield’s 6th Annual Summer Fair is running through Saturday, June 27, according to a statement.
Business Owners Agree: The Road to Downtown Recovery Runs Through Facts, Not Nostalgia
State Street's commercial vacancy rate is lower today than it was before the pandemic. The highest vacancy rates remain on blocks that are open to vehicle traffic.
With Rico Dowdle gone, Panthers need production from backup RBs
Carolina's run-first offense will need backups Jonathon Brooks, Trevor Etienne and AJ Dillon to support the RB1.
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
Notre Dame 2026 Player Profile: Wide Receiver Devin Fitzgerald
As the son of an NFL legend, this physical Arizona standout is already flashing elite route-running and contested-catch skills after a dominant spring debut in South Bend.
World Cup 2026: USMNT stunned by Türkiye in stoppage time, losing perfect group stage run
As Colorado votes, rural voter politics could influence key races
Rural doesn’t necessarily mean conservative, and the opinions of these 10 voters run the gamut.
What we learned as Bryce Harper caps Phillies' shocking comeback trilogy
The Phillies erased another five-run deficit, rallied late again and reached the season’s halfway point with another reminder of how much has changed.
Troy Melton magnificent but Tigers’ offence falters in loss
Troy Melton had a perfect game into the sixth. Unfortunately, baseball games are nine innings and runs are required.
Ex-NFL player Doug Martin's family sue Oakland police, allege restraint asphyxia in fatal mental health crisis
Parents of former NFL running back Doug Martin file wrongful death lawsuit alleging he died from restraint asphyxia caused by Oakland police.
YouTube Shorts are getting even shorter with an update that lets you double the playback speed
YouTube Shorts is getting a makeover.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Who is Anuk Karunaratne? Meet the Cardinals’ new President of Business Operations
The St. Louis Cardinals formally promoted Anuk Karunaratne to the role of President of Business Operations on Wednesday as the franchise unveiled changes to its organizational leadership structure.